跳至主要内容
临床试验/EUCTR2009-015780-14-AT
EUCTR2009-015780-14-AT进行中(未招募)不适用

The effect of high dose remifentanil on the reversal of established sunburn-induced hyperalgesia in human volunteers - High-Dose-RemiSun

Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien0 个研究点开始时间: 2009年11月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Men or women, aged between 19 and 40 years
  • Body mass index between 15th and 85th percentile
  • Normal findings in the medical history and physical examination
  • Drug free for 1 week prior to the study day
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Regular use of medication especially analgesics
  • Abuse of alcoholic beverages, drug abuse
  • History of asthma
  • Participation in a clinical trial in the 2 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 2 weeks before the first study day
  • Resting systolic blood pressure >135mmHg or diastolic blood pressure >85mmHg
  • History of allergy to any of the medications used in the study
  • Pregnancy or breast feeding
  • Acute skin diseases like sunburn or skin lesions on the relevant areas and UV sensitive skin conditions, like Xeroderma pigmentosa

研究者

发起方
Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien

相似试验